In the preceding three months, 4 analysts have released ratings for Corcept Therapeutics (NASDAQ:CORT), presenting a wide array of perspectives from bullish to bearish.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
---|---|---|---|---|---|
Total Ratings | 4 | 0 | 0 | 0 | 0 |
Last 30D | 2 | 0 | 0 | 0 | 0 |
1M Ago | 1 | 0 | 0 | 0 | 0 |
2M Ago | 0 | 0 | 0 | 0 | 0 |
3M Ago | 1 | 0 | 0 | 0 | 0 |
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $41.0, along with a high estimate of $44.00 and a low estimate of $38.00. This current average reflects an increase of 6.03% from the previous average price target of $38.67.
Diving into Analyst Ratings: An In-Depth Exploration
The standing of Corcept...
Login or create a forever free account to read this news
Sign up/Log in